CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 821 - 830 of 867
Study Number Lead Group Study Title CIRB Study Status
A061402 Alliance Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy Adult CIRB - Late Phase Emphasis Available to Open
EA6174 ECOG-ACRIN STAMP: Surgically Treated Adjuvant Merkel cell Carcinoma with Pembrolizumab, a Phase III Trial Adult CIRB - Late Phase Emphasis Available to Open
AALL0331 COG Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL): A Phase III Group-Wide Study Pediatric CIRB Available to Open
NWU2015-06-03 CLO-Northwestern University Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer Cancer Prevention and Control CIRB Available to Open
NWU2014-04-01 CLO-Northwestern University Statin Therapy to Reduce the Risk of Recurrent Pancreatitis Cancer Prevention and Control CIRB Available to Open
ALTE2031 COG StepByStep: A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention among Adolescent and Young Adult Childhood Cancer Survivors Pediatric CIRB Available to Open
AAML18P1 COG Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP) Pediatric CIRB Available to Open
WF-1803CD NCORP-Wake Forest University Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices Cancer Prevention and Control CIRB Available to Open
CCTG MA.39 NCIC CTG Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer Adult CIRB - Late Phase Emphasis Available to Open
ACNS0821 COG Temozolomide with Irinotecan versus Temozolomide; Irinotecan plus Bevacizumab (NSC# 704865; BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood; A COG Randomized Phase II Screening Trial: A Groupwide Phase II Study Pediatric CIRB Available to Open
Displaying 821 - 830 of 867